The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan”

Abstract

The global burden of bacterial resistance remains one of the most serious public health concerns. Infections caused by multidrug-resistant (MDR) bacteria in critically ill patients require immediate empirical treatment, which may not only be ineffective due to the resistance of MDR bacteria to multiple classes of antibiotics, but may also contribute to the selection and spread of antimicrobial resistance. Both the WHO and the ECDC consider carbapenem-resistant Enterobacteriaceae (CRE), carbapenem-resistant Pseudomonas aeruginosa (CRPA), and carbapenem-resistant Acinetobacter baumannii (CRAB) to be the highest priority. The ability to form biofilm and the acquisition of multiple drug resistance genes, in particular to carbapenems, have made these pathogens particularly difficult to treat. They are a growing cause of healthcare-associated infections and a significant threat to public health, associated with a high mortality rate. Moreover, co-colonization with these pathogens in critically ill patients was found to be a significant predictor for in-hospital mortality. Importantly, they have the potential to spread resistance using mobile genetic elements. Given the current situation, it is clear that finding new ways to combat antimicrobial resistance can no longer be delayed. The aim of this review was to evaluate the literature on how these pathogens contribute to the global burden of AMR. The review also highlights the importance of the rational use of antibiotics and the need to implement antimicrobial stewardship principles to prevent the transmission of drug-resistant organisms in healthcare settings. Finally, the review discusses the advantages and limitations of alternative therapies for the treatment of infections caused by these “titans” of antibiotic resistance.

Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic

“…Unfortunately, numerous A. baumannii strains resistant to all known antibiotics have now been reported. Moreover, this emerging resistance profile is in synergism with the uncanny ability of A. baumannii to survive for prolonged periods in a hospital environment [ 67 ]. It privileges the seriously ill within ICUs and results in a range of infectious syndromes in military personnel injured in the Iraq and Afghanistan conflicts [ 68 ] and more recently in the war in Ukraine [ 69 ].…”

The potential of Spirulina platensis to substitute antibiotics in Japanese quail diets: impacts on growth, carcass traits, antioxidant status, blood biochemical parameters, and cecal microorganisms

“…Antibiotic use in food production has resulted in antibiotic resistance, antibiotic residues in food, and a decline in the diversity of normal gut microflora ( Abd El-Hack et al, 2022b , c ). The presence of antibiotic residues in chicken products, such as eggs or meat, is detrimental to human health because these compounds cause pathogenic microorganisms found in human flora to develop resistance to these antibiotic groups ( Mancuso et al, 2023 ).…”

AMPActiPred: A three‐stage framework for predicting antibacterial peptides and activity levels with deep forest

“…The World Health Organization ranks antibiotic resistance among the top 10 global public health threats. According to a comprehensive large-scale study utilizing data from 204 countries, an estimated 1.75 million deaths occurred due to antibiotic-resistant infections in 2019, with antibiotic resistance playing a role in 4.95 million deaths, which underscores the greater lethality of antibioticresistant infections compared to HIV/AIDS or malaria (Balasubramanian et al, 2023;Mancuso et al, 2023). Enhanced morbidity rates are evident, with longer durations of illness and increased severity of infections due to a diminishing armamentarium of effective antibiotics (Siegel, 2008;Talbot et al, 2006).…”